ConductScience.org, home

Paper36968348

Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: A case report.

Zhong P and 5 others. Clin Case Rep, 2023. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: A case report. Papers, record 36968348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36968348

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: A case report.
PubMed
Journal
Clin Case Rep
PubMed
Year
2023
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.79
iCite
Revised in PubMed
2024-09-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhong PPenghttps://orcid.org/0000-0002-0347-4514
2Zhang CCuizhen
3Guan HHongshan
4Yan JJie
5He MMengying
6Zhou XXiaoyang

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136968348Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: A case report.Clin Case Rep2023https://conductscience.org/library/papers/36968348PubMed
231960755Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment.J Am Heart Assoc2020https://conductscience.org/library/papers/31960755PubMed
328485549Immune-related fulminant myocarditis in a patient receiving ipilimumab therapy for relapsed chronic myelomonocytic leukaemia.Eur J Heart Fail2017https://conductscience.org/library/papers/28485549PubMed
427806233Fulminant Myocarditis with Combination Immune Checkpoint Blockade.N Engl J Med2016https://conductscience.org/library/papers/27806233PubMed
528529185CARE guidelines for case reports: explanation and elaboration document.J Clin Epidemiol2017https://conductscience.org/library/papers/28529185PubMed
632158597Clinical Characteristics and Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors.Immune Netw2020https://conductscience.org/library/papers/32158597PubMed
711209085Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice.Science2001https://conductscience.org/library/papers/11209085PubMed
829567210Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.J Am Coll Cardiol2018https://conductscience.org/library/papers/29567210PubMed
932765397Immune Checkpoint Inhibitor-Induced Myasthenia Gravis.Front Neurol2020https://conductscience.org/library/papers/32765397PubMed
1028666240Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors.Eur J Cancer2017https://conductscience.org/library/papers/28666240PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42826309Literature review of myasthenia gravis complicated by myocardial damage.Medicine (Baltimore)2026https://conductscience.org/library/papers/42826309PubMed
41789342Unraveling Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities: Pathway Insights, Mechanisms, and Emerging Therapeutic Targets.Rev Cardiovasc Med2026https://conductscience.org/library/papers/41789342PubMed
41188194Myocarditis and Myasthenia Gravis Induced by Camrelizumab in a Patient With Metastatic B2 Thymoma: A Case Report.Thorac Cancer2025https://conductscience.org/library/papers/41188194PubMed
40519300Immune-related myocarditis characterized by malignant arrhythmia caused by conduction system involvement: case report and literature review.Front Oncol2025https://conductscience.org/library/papers/40519300PubMed
40178703Updates in Diagnosis and Treatment of Immune Checkpoint Inhibitor Myocarditis.Curr Cardiol Rep2025https://conductscience.org/library/papers/40178703PubMed
39301255Myasthenia gravis and myocarditis induced by chemoimmunotherapy in locally advanced gastric cancer: A case report.Exp Ther Med2024https://conductscience.org/library/papers/39301255PubMed
39263485Therapeutic agents for steroid-refractory immune checkpoint inhibitor-related myocarditis: a narrative review.Cardiovasc Diagn Ther2024https://conductscience.org/library/papers/39263485PubMed
36968348Myocarditis and myasthenia gravis induced by immune checkpoint inhibitor in a patient with relapsed thymoma: A case report.Clin Case Rep2023https://conductscience.org/library/papers/36968348PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36968348

GET https://conductscience.org/api/papers/v1/36968348/authors